Bacterial translocation as a source of Dacron-graft contamination in experimental aortic operation: the importance of controlling SIRS

Surgery

Volumn 140, Issue 1, 2006, Pages 83-92

  Lozano, Francisco S ^a,c   Cascajo, Carlos ^a   García Sánchez, Enrique ^b   Barros, Marcello B ^a   García Criado, Francisco J ^c   Parreño, Felipe ^c   García Sánchez, José Elias ^b   Gómez Alonso, Alberto ^c  

^a Service of Vascular Surgery   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DACRON; INDUCIBLE NITRIC OXIDE SYNTHASE; MOLSIDOMINE; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; AORTA DISSECTION; AORTA SURGERY; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIOLOGY; BLEEDING; BLOOD; BLOOD VOLUME; BYPASS SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMPLANTATION; KIDNEY; LIVER; MALE; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROTEIN EXPRESSION; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WESTERN BLOTTING;

ANIMALS; AORTA; BACTERIA; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; KIDNEY; LIVER; MALE; MOLSIDOMINE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; POLYETHYLENE TEREPHTHALATES; SWINE; SWINE, MINIATURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745961937     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.01.011     Document Type: Article

References (51)

1. Guarner F., and Malagelada J.R. Gut flora in health and disease. Lancet 361 (2003) 512-519
2. Steinberg S.M. Bacterial translocation. what it is and what it is not. Am J Surg 186 (2003) 301-305
3. Woodcock N.P., el-Barghouti N., Perry E.P., and MacFies J. Is bacterial translocation a cause of aortic graft sepsis?. Eur J Vasc Endovasc Surg 19 (2000) 433-434
4. Woodcock N.P., Sudheer V., El-Barghouti N., Perry E.P., and MacFie J. Bacterial translocation in patients undergoing abdominal aortic aneurysm repair. Br J Surg 87 (2000) 439-442
5. Lozano F.S., Barros M.B., Fresnadillo M.J., Garcia-Criado F.J., and Gomez-Alonso A. Nitric oxide prevents the bacterial translocation and inhibits the systemic inflammatory response produced by implantation of a vascular prosthesis followed by Zymosan A. Inflamm Res 54 (2005) 261-270
6. Lozano F., Garcia F.J., Fresnadillo M.J., Garcia E., Garcia J.E., and Gomez A. Systemic inflammatory response induced by Dacron and modulation by antimicrobial agents. experimental study. J Surg Res 107 (2002) 7-13
7. Lozano F.S., López-Novoa J.M., Rodríguez J.M., Barros M.B., García-Criado F.J., Nicolas J.L., et al. Exogenous nitric oxide modulates the systemic inflammatory response and improves kidney function after risk-situation abdominal aortic surgery. J Vasc Surg 42 (2005) 129-139
8. Roumen R.M.H., Van der Vliet A., Wevers R.A., and Goris R.J.A. Intestinal permeability is increased after mayor vascular surgery. J Vasc Surg 17 (1993) 734-737
9. Holzheimer R.G., Gross J., and Schein M. Pro and anti-inflammatory cytokine response in abdominal aortic aneurysm repair. a clinical model of ischemia-reperfusion. Shock 11 (1999) 305-310
10. Lau L.L., Halliday M.I., Lee B., Hannon R.J., Gardiner K.R., and Soong C.V. Intestinal manipulation during elective aortic aneurysm surgery leads to portal endotoxemia and mucosal barrier dysfunction. Eur J Vasc Endovasc Surg 19 (2000) 619-624
11. Taner I., Ayhan M., Berkem H., Berkem R., and Acar N. The presence of hemorrhagic shock increases the rate of bacterial translocation in blunt abdominal trauma. J Trauma 44 (1998) 171-174
12. Angele M.K., and Faist E. Clinical review. immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 6 (2002) 298-305
13. Lemaire L.C., van Lanschot J.J.B., Stoutenbeek C.P., Deventer S.J.H., Wells C.L., and Gouma D.J. Bacterial translocation in multiple organ failure. a cause or epiphenomenon still unproven. Br J Surg 84 (1997) 1340-1350
14. Deitch E.A., Rutan R., and Waymack J.P. Trauma, shock, and gut translocation. New Horiz 4 (1996) 289-299
15. Sedman P.C., MacFie J., Sagar P., Mitchell C.J., May J., Mancey-Jones B., et al. The prevalence of gut translocation in humans. Gastroenterology 107 (1994) 643-649
16. O'Boyle C.J., MacFie J., Mitchell C.J., Johnstone D., Sagar P., and Sedman P.C. Microbiology of bacterial translocation in humans. Gut 42 (1998) 29-35
17. Cohen J.R., Sardari F., Paul J., Parikh S., Sarfati I., Danna D., et al. Increased intestinal permeability. implications for thoracoabdominal aneurysm repair. Ann Vasc Surg 6 (1992) 433-437
18. Lau L.L., Halliday M.I., Smye M.G., Lee B., Hannon R.J., Gardiner K.R., et al. Extraperitoneal approach reduces intestinal and renal dysfunction in elective abdominal aortic aneurysm repair. Int Angiol 20 (2001) 282-287
19. Corson R.J., Paterson I.S., O'Dwyer S.T., Rowland P., Kirkman E., Little R.A., et al. Lower limbs ischaemia and reperfusion alters gut permeability. Eur J Vasc Surg 6 (1992) 158-163
20. Yassin M.M., Barros D'Sa A.A., Parks T.G., McCaigue M.D., Leggett P., Halliday M.I., et al. Lower limb ischaemia-reperfusion injury alters gastrointestinal structure and function. Br J Surg 84 (1997) 1425-1429
21. Mora E.M., Cardona M.A., and Simmons R.L. Enteric bacteria and ingested inert particles translocate to intraperitoneal prosthetic materials. Arch Surg 126 (1991) 157-163
22. Mainous M.R., Tso P., Berg R.D., and Deitch E.A. Studies of the route magnitude and time curve of bacterial translocation in a model of systemic inflammation. Arch Surg 126 (1991) 33-37
23. Deitch E.A. Bacterial translocation or lymphatic drainage of toxic products from the gut. what is important in human beings?. Surgery 131 (2002) 241-244
24. Debelian G.J., Olsen I., and Tronstad L. Systemic diseases caused by oral microorganisms. Endod Dent Traumatol 10 (1994) 57-65
25. Nayci A., Atis S., Talas D.U., and Ersoz G. Rigid bronchoscopy induces bacterial translocation. an experimental study in rats. Eur Respir J 21 (2003) 749-752
26. Alican I., and Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 270 (1996) G225-G237
27. Mishima S., Xu D., Lu Q., and Deitch E.A. Bacterial translocation is inhibited in inducible nitric oxide synthase knockout mice after endotoxin challenge but not in a model of bacteria overgrowth. Arch Surg 132 (1997) 1190-1195
28. Suzuki Y., Deitch E.A., Mishima S., Lu Q., and Xu D. Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit Care Med 28 (2000) 3692-3696
29. Mishima S., Xu D., and Deitch E.A. Increased in endotoxin-induced mucosal permeability is related to increased nitric oxide synthase activity using the Ussing chamber. Crit Care Med 27 (1999) 880-886
30. Sorrells D.L., Friend C., Koltuksuz U., Courcoulas A., Boyle P., Garrett M., et al. Inhibition of nitric oxide with amino guanidine reduces bacterial translocation after endotoxin challenge in vivo. Arch Surg 131 (1996) 1155-1163
31. Unno N., Wang H., Menconi M.J., Tytgat S.H., Larkin V., Smith M., et al. Inhibition inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 13 (1997) 1246-1257
32. Kavuklu B., Agalar C., Guc M.O., and Sayek I. Evidence that amino guanidine inhibits endotoxin-induced bacterial translocation. Br J Surg 85 (1998) 1103-1106
33. Langrehr J.M., Machens C., Zill E., Leder K., Nussler A., Hoffman R., et al. Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis. Transplantation 69 (2000) 2415-2421
34. Mishima S., Xu D., Lu Q., and Deitch E.A. The relationships among nitric oxide production, bacterial translocation, and intestinal injury after endotoxin challenge in vivo. J Trauma 44 (1998) 175-182
35. Hua T.C., and Moochhala S.M. Role of nitric oxide in hemorrhagic shock-induced bacterial translocation. J Surg Res 93 (2000) 247-256
36. Chen L.W., Hsu C.M., Wang J.S., Chen J.S., and Chen S.C. Specific inhibition of iNOS decreases the intestinal mucosal peroxynitrite levels and improves the barrier function after thermal injury. Burns 24 (1998) 699-705
37. Hsu C.M., Liu C.H., and Chen L.W. Nitric oxide synthase inhibitor ameliorates oral total parenteral nutrition-induced barrier dysfunction. Shock 13 (2000) 135-139
38. Simsek I., Mas M.R., Yasar M., Ozyurt M., Saglamkaya U., Deveci S., et al. Inhibition of inducible nitric oxide synthase reduces bacterial translocation in a rat model of acute pancreatitis. Pancreas 23 (2001) 296-301
39. Dickinson E., Tuncer R., Nadler E., Boyle P., Alber S., Watkins S., et al. NOX, a novel nitric oxide scavenger, reduce bacterial translocation in rat after endotoxin challenge. Am J Physiol 277 (1999) G1281-G1287
40. Gianotti L., Alexander J.W., Pyles T., and Fukushima R. Arginine supplemented diets improve survival in gut derives sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide. Ann Surg 217 (1993) 644-654
41. Adawi D., Kasravi B., Molin G., and Jeppsson B. Effect of lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology 25 (1997) 642-647
42. Horton J.W., White J., Maass D., and Sanders B. Arginine in burn injury improves cardiac performance and prevents bacterial translocation. J Appl Physiol 84 (1998) 695-702
43. Cevikel M.H., Ozgun H., Boylu S., Demirkiran A.E., Sakarya S., and Culhaci N. Nitric oxide regulates bacterial translocation in experimental acute edematous pancreatitis. Pancreatology 3 (2003) 329-335
44. Villarreal D., Grisham M.B., and Granger D.N. Nitric oxide donors improve gut function after prolonged hypothermic ischemia. Transplantation 59 (1995) 685-689
45. Göl M.K., Nisanoglu V., Iscan Z., Balci M., Kandemir O., and Tasdemir O. Inhibition of systemic inflammatory response with sodium nitroprusside in open heart surgery. J Cardiovasc Surg 43 (2002) 803-809
46. Azuara D., Sola A., Hotter G., Calatayud L., Jaurrieta E., and de Oca J. Administration of nitric oxide with caspase inhibitors minimizes bacterial translocation in experimental intestinal transplantation. Transplantation 27 (2004) 177-183
47. Garcia-Criado F.J., Eleno N., Santos-Benito F., Valdunciel J.J., Reverte M., Lozano-Sanchez F.S., et al. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation 66 (1998) 982-990
48. Lozano F.S., Barros M.B., Garcia F.J., and Gomez A. Exogenous nitric oxide can control SIRS and downregulate NFkB. J Surg Res 124 (2005) 52-58
49. Ji J.Y., and Diamond S.L. Exogenous nitric oxide activates the endothelial glucocorticoid receptor. Biochem Biophys Res Com 318 (2004) 192-197
50. Kuo Y.R., Wang F.S., Jeng S.F., Lutz B.S., Huang H.C., and Yang K.D. Nitrosoglutathione improves blood perfusion and flap survival by suppressing iNOS by protecting eNOS expression in the flap vessels after ischemia/reperfusion injury. Surgery 135 (2004) 437-446
51. Harkin D.W., Rubin B.B., Romaschin A., and Lindsay T.F. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm. J Surg Res 120 (2004) 230-241